Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

FLT3 length mutations as marker for follow-up studies in acute myeloid leukaemia.

Acta haematologica - 1 Jan 2004

Schnittger Susanne, Schoch Claudia, Kern Wolfgang, Hiddemann Wolfgang, Haferlach Torsten

Abstract excerpt

Length mutations within the FLT3 gene (FLT3-LM) can be found in 23% of acute myeloid leukaemia (AML) and thus are the most frequent mutations in AML. FLT3-LM are highly correlated with AML with normal karyotype and other cytogenetic aberrations of the prognostically intermediate group. This group is supposed to be a mixed group of AML with differences in the underlying pathogenesis. For more individualized...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Disease
Share to Biomarkers
Share to fms-Like Tyrosine Kinase 3

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Follow-Up Studies

Share to Leukemia, Myeloid

Share to Neoplasm, Residual

Share to Proto-Oncogene Proteins

Share to Receptor Protein-Tyrosine Kinases

Source

Identifiers

PMID: 15179006
DOI: 10.1159/000077561

Genes

FLT3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

FLT3 length mutations as marker for follow-up studies in acute myeloid leukaemia.PMID 15179006Read ↗

Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease.Semantic proximity Read ↗

Minimal residual disease monitoring based on FLT3 internal tandem duplication in adult acute myeloid leukemia.Semantic proximity Read ↗

Analyses of minimal residual disease based on Flt3 mutations in allogeneic peripheral blood stem cell transplantation.Semantic proximity Read ↗

A new and recurrent activating length mutation in exon 20 of the FLT3 gene in acute myeloid leukemiaSemantic proximity Read ↗

[FMS-like tyrosine kinase 3 gene mutation in acute myeloid leukemia detected by denaturing PAGE and its clinical significance].Semantic proximity Read ↗

Minimal residual disease based on patient specific Flt3-ITD and -ITT mutations in acute myeloid leukemia.Semantic proximity Read ↗

Prognostic significance of FLT3-ITD length in AML patients treated with intensive regimens.Semantic proximity Read ↗

Prognostic implications of the presence of FLT3 mutations in patients with acute myeloid leukemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.